GLP-1 weight-loss drugs drive shifts in consumer spending and industry trends

The widespread use of GLP-1 weight-loss medications, such as Ozempic and Mounjaro, is driving significant shifts in consumer behavior and various business sectors.

In the United Kingdom, the repair chain Timpson reported a 680% increase in requests for extra belt holes, a trend attributed to customers losing weight. The company has offered this service for free, requesting instead a small donation to charity.

In the food industry, McDonald’s is adapting to the changing dietary habits of consumers using these drugs. With approximately 11% of Americans using GLP-1 medications, the company is planning an $8.5 billion overhaul that includes introducing smaller, protein-dense meal options to accommodate users who prioritize muscle maintenance while managing calorie intake.